Skip to contentC
Cannabis Suisse Corp.
C
CSUICannabis Suisse Corp. Q2 2024 · 10-Q
Revenue$7.50K$7.50K— vs Q2 2023 Net Income-$54.80K-$54.80KN/M vs Q2 2023 EPS Diluted$0.00$0.00no prior Q2 2023 on file The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cannabis Suisse Corp. · CIK 1680132 · Engraved from SEC EDGAR
Operating Cash Flowderived-$18,485N/M Margins · derivedGross margin8.3%
Operating margin-676.0%
Net margin-730.6%
ended Nov 30, 2023 · filed Jan 12, 2024 · 43 d after period end